Literature DB >> 15633809

The effect of Gu-Sui-Bu (Drynaria fortunei) on bone cell activity.

Jui-Sheng Sun1, Brigitte L Thériault, Gail I Anderson.   

Abstract

We investigated the effects of Gu-Sui-Bu using in vitro bone cell cultures. Primary rabbit and mouse marrow cells were cultured with or without five different concentrations of Gu-Sui-Bu extract. Osteoclast numbers were assessed using tartrate-resistant acid phosphatase (TRAP) positive cell counts and for function, osteoclast resorption pits on bovine bone slices were performed. Alkaline phosphatase (AP) positive cell counts and mineralized nodule formation were examined to assess osteoblast function with Gu-Sui-Bu. TRAP+ osteoclast numbers increased, as did the number and size of resorption pits with 0.001 mg/ml of extract. Low doses of extract did not alter AP+ colony number or mineralized nodule formation, but both were inhibited by doses of 0.1 mg/ml or higher. The highest dose of extract (10 mg/ml) inhibited proliferation of all cell types. At 0.01 and 0.001 mg/ml doses, RANKL increased over time; however, osteoprotegerin levels only increased at doses > or = 0.1 mg/ml. Resorption pit formation was decreased without alteration in mature multinucleated (TRAP+) cell counts only at the highest dose of the putative active ingredient of Gu-Sui-Bu. In summary, lower concentrations of Gu-Sui-Bu extract had positive effects on osteoclast proliferation, survival and resorptive activity that may be mediated through enhanced prostaglandin secretion. However, high doses of extract proved detrimental to osteoclast and osteoblast survival. No effect of low doses of Gu-Sui-Bu extract was seen in osteoblast cultures. High doses of the putative active ingredient of Gu-Sui-Bu showed mild inhibition of mouse osteoclast function.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15633809     DOI: 10.1142/S0192415X0400234X

Source DB:  PubMed          Journal:  Am J Chin Med        ISSN: 0192-415X            Impact factor:   4.667


  8 in total

Review 1.  Role of Traditional Chinese Medicine in Bone Regeneration and Osteoporosis.

Authors:  Zhicai Peng; Ronghua Xu; Qinjian You
Journal:  Front Bioeng Biotechnol       Date:  2022-05-31

2.  Chinese herbal prescriptions for osteoarthritis in Taiwan: analysis of National Health Insurance dataset.

Authors:  Fang-Pey Chen; Ching-Mao Chang; Shinn-Jang Hwang; Yu-Chun Chen; Fun-Jou Chen
Journal:  BMC Complement Altern Med       Date:  2014-03-07       Impact factor: 3.659

3.  Earthworm (Pheretima aspergillum) extract stimulates osteoblast activity and inhibits osteoclast differentiation.

Authors:  Yuan-Tsung Fu; Kuo-Yu Chen; Yueh-Sheng Chen; Chun-Hsu Yao
Journal:  BMC Complement Altern Med       Date:  2014-11-11       Impact factor: 3.659

4.  Anti-Osteoporotic and Anti-Adipogenic Effects of the Water Extract of Drynaria roosii Nakaike in Ovariectomized Mice Fed a High-Fat Diet.

Authors:  Seon-A Jang; Youn-Hwan Hwang; Taesoo Kim; Ami Lee; Hyunil Ha
Journal:  Molecules       Date:  2019-08-22       Impact factor: 4.411

5.  Ethanol Extracts of Fresh Davallia formosana (WL1101) Inhibit Osteoclast Differentiation by Suppressing RANKL-Induced Nuclear Factor- κ B Activation.

Authors:  Tzu-Hung Lin; Rong-Sen Yang; Kuan-Chin Wang; Dai-Hua Lu; Houng-Chi Liou; Yun Ma; Shao-Han Chang; Wen-Mei Fu
Journal:  Evid Based Complement Alternat Med       Date:  2013-09-28       Impact factor: 2.629

6.  Utilization Pattern of Traditional Chinese Medicine among Fracture Patients: A Taiwan Hospital-Based Cross-Sectional Study.

Authors:  Chu-Yao Tseng; Ching-Wen Huang; Hsin-Chia Huang; Wei-Chen Tseng
Journal:  Evid Based Complement Alternat Med       Date:  2018-09-30       Impact factor: 2.629

7.  Drynaria fortunei Promoted Angiogenesis Associated With Modified MMP-2/TIMP-2 Balance and Activation of VEGF Ligand/Receptors Expression.

Authors:  Sheng-Teng Huang; Cheng-Chieh Chang; Jong-Hwei S Pang; Hung-Sen Huang; Shen-Chieh Chou; Ming-Ching Kao; Huey-Ling You
Journal:  Front Pharmacol       Date:  2018-09-21       Impact factor: 5.810

8.  Guzhi Zengsheng Zhitongwan, a Traditional Chinese Medicinal Formulation, Stimulates Chondrocyte Proliferation through Control of Multiple Genes Involved in Chondrocyte Proliferation and Differentiation.

Authors:  Baojin Yao; Bocheng Lu; Hongwei Gao; Mei Zhang; Xiangyang Leng; Daqing Zhao
Journal:  Evid Based Complement Alternat Med       Date:  2018-09-12       Impact factor: 2.629

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.